Announced Mon, 27 Jul · 20:45 IST
Board meeting on Jul 30 to consider Q1 results and share-swap acquisitions
Results View source PDF
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹15.84
prior close
₹15.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4-0.5+0.1-0.3——————————
Up moveDown movePending
AI summary
Board meeting on July 30, 2026 will consider: (1) Unaudited standalone and consolidated Q1 FY27 results for quarter ended June 30, 2026 with limited auditor review; (2) Share swap to acquire remaining 32.52% in Apiqo Organics and 43.33% in Bizotic LifeScience, making both wholly owned subsidiaries, via preferential fresh equity share issuance (non-cash consideration); (3) Any other business.
Likely market impact
Q1 earnings due; share swap will dilute existing shareholders but adds two wholly owned subsidiaries without cash outflow.